FDA Silence “Speaks Volumes” On Consent Decree Intentions – Levine
This article was originally published in The Tan Sheet
Executive Summary
FDA reluctance to discuss results from a 483 inspection with a company could be a red flag that an injunction against the firm is imminent, according to Arthur Levine of Arnold and Porter